Solas Capital Management, LLC Processa Pharmaceuticals, Inc. Put Options Transaction History

Solas Capital Management, LLC

  • $125 Million
  • Q3 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $14.6M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Solas Capital Management, LLC Portfolio

Follow Solas Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solas Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Solas Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email